SEC Form 4 · accession 0001144204-16-128488
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark I Greene
Director
Period of report
Oct 17, 2016
Accepted (ET)
Oct 18, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2016 | A | 11,413 | $0.87 | A | 40,838 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from Issuer in lieu of cash compensation for board services during the third quarter of 2016.